logo
logo

Transcarent Raises $200 Million In Series C Funding Highlighting Growing Demand For A Different Health And Care Experience Aligned With The Needs Of Self-Insured Employers

Jan 11, 2022•over 3 years ago

Amount Raised

$200 Million

Round Type

series c

Palo Alto

Description

Transcarent, a new and different health and care experience company for employees of self-insured employers and their families, today announced a $200 million Series C investment led by Kinnevik and Human Capital, with participation from Ally Bridge Group and leading health systems including Northwell Health, Intermountain Healthcare, and Rush University Medical Center. The funding round also included participation from existing investors, including General Catalyst, 7wireVentures, Alta Partners, Merck Global Health Innovation Fund, Jove Equity Partners, Threshold Ventures, and GreatPoint Ventures.

Company Information

Company

Transcarent

Location

Palo Alto, California, United States

About

Transcarent is a new and different health and care experience company putting people back in charge. Using a combination of software, technology, Health Guides, and data science, Transcarent empowers consumers with the kind of unbiased information, trusted guidance and access to high-value care that leads to better care, better outcomes, and more cost-effective decisions and allows Members to share in the benefits of their decisions. Transcarent believes that having the right information, tools, and incentives in the decision-making process can positively transform the way we all experience our health and care. For more Information, visit us at www.transcarent.com and follow us on Twitter or LinkedIn.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech